OTCMKTS:PBIO Pressure BioSciences (PBIO) Stock Price, News & Analysis → A Silent Invasion of America (From The Freeport Society) (Ad) Free PBIO Stock Alerts $0.14 +0.01 (+7.47%) (As of 06/13/2024 ET) Add Compare Share Share Today's Range$0.13▼$0.1550-Day Range$0.13▼$0.3052-Week Range$0.13▼$0.86Volume94,746 shsAverage Volume46,610 shsMarket Capitalization$5.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get Pressure BioSciences alerts: Email Address Ad The Freeport SocietyDemocrats’ “break glass for emergency” candidate for 2024Nate Silver has been a celebrity pundit since at least the 2008 election, when he correctly predicted the winner in 49 of 50 states, and nailed all 35 Senate election outcomes. But interestingly, one man reached the same conclusion as Nate Silver a long time ago…For full details, click here. About Pressure BioSciences Stock (OTCMKTS:PBIO)Pressure BioSciences, Inc. develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources. It offers Barocycler instrumentations comprising Barocycler 2320EXT, Barocycler HUB880, Barocycler HUB440, and the Shredder SG3. The company also distributes cell disruption equipment, parts, and consumables. In addition, it offers Barocycler consumable products, such as PCT MicroTubes, PCT MicroCaps, PCT-Micro Pestle, and pressure used to lyse samples for extraction tubes, as well as application specific kits, including consumable products and reagents. The company serves researchers at academic laboratories, government agencies, biotechnology companies, pharmaceutical firms, and other life science institutions. It has collaborations with RedShiftBio Inc.; Inova Schar Cancer Center; NYU; Leica Microsystems, GmbH; Steinbeis Centre for biopolymer analysis and biological mass spectrometry; The Ohio State University; University of Delaware; and Cedars Sinai Medical Center. The company was formerly known as Boston Biomedica, Inc. and changed its name to Pressure BioSciences, Inc. in September 2014. The company was incorporated in 1978 and is based in South Easton, Massachusetts.Read More PBIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PBIO Stock News HeadlinesJune 13 at 10:13 AM | globenewswire.comPressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ETApril 24, 2024 | bbc.co.ukThe big blood pressure experimentApril 22, 2024 | msn.comPacBio moved to Neutral at JPMorgan after guidance cutApril 2, 2024 | finance.yahoo.comPressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”April 2, 2024 | globenewswire.comPressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”March 25, 2024 | nytimes.comThe Best Pressure WasherMarch 5, 2024 | nypost.comThe 8 best blood pressure monitors, approved by expertsFebruary 26, 2024 | globenewswire.comUncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.February 23, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Insider TradesFebruary 15, 2024 | finance.yahoo.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 15, 2024 | globenewswire.comPressure BioSciences Completes Relocation into New Manufacturing Facility, Consolidating R&D with Expanded UltraShear Equipment Development and Contract ManufacturingFebruary 6, 2024 | forbes.comWrist Blood Pressure Monitors: Are They Accurate?February 5, 2024 | forbes.comBest Blood Pressure Monitors For 2024February 5, 2024 | finance.yahoo.comUncle Bud’s to Launch New Premium Health and Wellness Products Leveraging Pressure BioSciences UltraShear Processing for Revolutionary Product EffectivenessJanuary 26, 2024 | msn.comPressure Biosciences Acquires Uncle Bud’s AssetsJanuary 22, 2024 | finance.yahoo.comPressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & SalesJanuary 20, 2024 | benzinga.comPressure BioSciences Stock (OTC:PBIO) Dividends: History, Yield and DatesJanuary 16, 2024 | finance.yahoo.comPressure BioSciences’ New Consumer Products Unit Continues Long Sales Relationship with Dominant U.S. Retailer, Launching 2024 with Quarter Million Dollar Shipment in JanuaryJanuary 15, 2024 | benzinga.comToni Braxton Cheers PBIO's Acquisition Of Cannabis And Hemp Co. Uncle Bud'sJanuary 12, 2024 | theglobeandmail.comHemp-CBD Market Demand Gaining Momentum While Projected to Reach $16 Billion By 2025January 11, 2024 | markets.businessinsider.comPressure BioSciences To Acquire Uncle Bud's - Quick FactsJanuary 4, 2024 | finance.yahoo.comPressure BioSciences’ BaroFold Platform Expected to Revolutionize Biopharmaceutical Production with Help from New Computational (AI/ML) TechnologiesDecember 21, 2023 | finance.yahoo.comPressure BioSciences' Celebrates Second Groundbreaking Article Published This Month on its Transformative, Patented UltraShear Technology Processing PlatformDecember 12, 2023 | finance.yahoo.comPressure BioSciences’ UltraShear Platform Maintains Nutritional, Sensory, and Other Important Qualities of Liquid Foods While Inactivating Foodborne Bacterial SporesDecember 1, 2023 | finance.yahoo.comPressure BioSciences and Veterans Service Team Launch UltraShear Best-in-Class Nano-CBD Topical Spray - MMA Champ Cat Zingano Now Official VST AmbassadorSee More Headlines Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/17/2020Today6/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Analytical instruments Sub-IndustryN/A Current SymbolOTCMKTS:PBIO CUSIPN/A CIK830656 Webwww.pressurebiosciences.com Phone508-230-1828Fax508-230-1829Employees16Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($1.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,310,000.00 Net Margins-1,482.05% Pretax Margin-1,050.15% Return on EquityN/A Return on Assets-1,601.33% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.02 Sales & Book Value Annual Sales$1.98 million Price / Sales2.58 Cash FlowN/A Price / Cash FlowN/A Book Value($2.56) per share Price / Book-0.06Miscellaneous Outstanding Shares35,490,000Free Float31,654,000Market Cap$5.10 million OptionableNot Optionable Beta-0.21 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Richard T. Schumacher (Age 74)Founder, President, CEO, Treasurer, Interim CFO, Clerk & Director Comp: $320.54kDr. Edmund Y. Ting Ph.D. (Age 69)Sc.D. Ph.D., Senior Vice President of Engineering Comp: $215.16kDr. Alexander V. Lazarev Ph.D. (Age 59)Vice President of Research & Development Comp: $202.27kJohn B. HollisterDirector of Sales & MarketingKey CompetitorsTalis BiomedicalNASDAQ:TLISAstrotechNASDAQ:ASTCScientific IndustriesOTCMKTS:SCNDPrecipioNASDAQ:PRPOCue HealthNASDAQ:HLTHView All Competitors PBIO Stock Analysis - Frequently Asked Questions How have PBIO shares performed in 2024? Pressure BioSciences' stock was trading at $0.33 at the beginning of the year. Since then, PBIO shares have decreased by 56.4% and is now trading at $0.1438. View the best growth stocks for 2024 here. Are investors shorting Pressure BioSciences? Pressure BioSciences saw a increase in short interest in May. As of May 31st, there was short interest totaling 26,500 shares, an increase of 516.3% from the May 15th total of 4,300 shares. Based on an average daily volume of 66,900 shares, the days-to-cover ratio is currently 0.4 days. View Pressure BioSciences' Short Interest. How were Pressure BioSciences' earnings last quarter? Pressure BioSciences, Inc. (OTCMKTS:PBIO) posted its quarterly earnings results on Tuesday, November, 17th. The company reported ($1.02) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($2.20) by $1.18. The firm earned $0.53 million during the quarter. Read the conference call transcript. What other stocks do shareholders of Pressure BioSciences own? Based on aggregate information from My MarketBeat watchlists, some companies that other Pressure BioSciences investors own include Advanced Micro Devices (AMD), Allena Pharmaceuticals (ALNA), Actinium Pharmaceuticals (ATNM), Anavex Life Sciences (AVXL), Aware (AWRE), Curaleaf (CURLF) and Walt Disney (DIS). How do I buy shares of Pressure BioSciences? Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PBIO) was last updated on 6/14/2024 by MarketBeat.com Staff From Our PartnersExecutive Order To Wipe Out Your Bank AccountsDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredThe Single Biggest Breakthrough of the Decade Billionaires, Jeff Bezos, Bill Gates, Warren Buffett, and Sir Richard Branson are rallying behind this technol...Porter & Company | SponsoredAn utter travestyThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredGold Prices Surge and This $0.32 Stock Is Reaping The RewardsGold prices are on the rise. This surge in gold prices is great news for gold mining stocks. Especially ...Market JAR | SponsoredEstee Lauder, MAC, and other beauty brands are raving about this emerging NYSE AI companyA Little-known NYSE Company is Empowering the Beauty Industry with Innovative AI and AR Tools.Financial Markets Daily | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pressure BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.